MRK vs ULBI · P/E 33, rev $16.61B vs rev $95.4M
Merck & Company Inc (MRK) versus Ultralife Corporation (ULBI) — a side-by-side from cached financials, not a winner call.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Rob Davis.
Ultralife Corporation (ULBI) is a electrical equipment & parts company listed on NASDAQ.
Latest reported MRK revenue for 2026-06-30 was $16.61B. Net income was -$1.33B. Revenue was up 2.0% from 2026-03-31 to 2026-06-30. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Latest reported ULBI revenue for 2026-06-30 was $95.4M. Net income was $2.1M. ULBI currently screens at market cap $104.8M.
MRK currently screens at market cap $285.12B and trailing P/E 32.5. ULBI currently screens at market cap $104.8M.
Not investment advice. Open the MRK and ULBI stock pages for the full models.
Not investment advice.